Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
kidney disease
Biotech
Novartis, Versant hope to repeat Chinook’s success with Borealis
Borealis, which was jointly launched by Novartis and Versant, is working on next-generation RNA medicines for kidney disease.
James Waldron
Aug 22, 2024 8:00am
Baxter sells $4.5B kidney care unit to Carlyle Group for $3.8B
Aug 13, 2024 11:00am
Vertex pays $4.9 billion to hike Alpine’s immunology trail
Apr 10, 2024 5:30pm
Equillium delivers new lupus data to Ono's doorstep
Apr 1, 2024 10:53am
AstraZeneca axes IL-33 kidney disease program after seeing data
Feb 8, 2024 5:30am
Procyrion raises $57M to complete its percutaneous heart pump
Feb 5, 2024 11:35am